Skip to main content
Top
Published in: BMC Surgery 1/2022

Open Access 01-12-2022 | Liver Cirrhosis | Research

Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching

Authors: Zhaoqin Wu, Haodong Tang, Lishan Wang, Xiaoling Jin, Zhengqing Lei, Pinghua Yang, Jiahua Zhou

Published in: BMC Surgery | Issue 1/2022

Login to get access

Abstract

Objective

Most hepatocellular carcinoma (HCC) patients in China have some degree of liver cirrhosis. The effect of cirrhosis on the long-term prognosis of HCC patients after hepatectomy is still unclear. This study aimed to investigate the effect of liver cirrhosis on the prognosis of HCC patients after hepatectomy.

Methods

Data from patients who underwent hepatectomy and had pathologically confirmed HCC were retrospectively collected. The patients’ clinical pathological data were recorded. Propensity score matching (PSM) was used to eliminate the influence of potential confounding factors. The Kaplan–Meier method was used to calculate the recurrence-free survival (RFS) and overall survival (OS) rates, and Cox regression analysis was used to screen for independent risk factors affecting OS and RFS.

Results

A total of 1381 HCC patients who were initially treated with hepatectomy were included, including 797 patients with liver cirrhosis. The RFS and OS rates in the group with cirrhosis were significantly lower than those in the group without cirrhosis (after PSM, RFS: P < 0.001; OS: P = 0.001). Subgroup analysis showed that among patients with Barcelona Clinic Liver Cancer (BCLC) stage 0-B disease, RFS and OS were significantly lower in those with cirrhosis than in those without cirrhosis (both P < 0.05); while in patients with stage C disease, there was no significant difference between those with and without cirrhosis. In the group with cirrhosis, alpha-fetoprotein (AFP) > 400, intraoperative blood loss, tumor diameter > 5 cm, satellite lesions, and large vessel invasion were independent risk factors for RFS, while albumin-bilirubin (ALBI) grade, neutrophil-to-lymphocyte ratio (NLR), tumor diameter > 5 cm, satellite lesions, microvascular invasion, and macrovascular invasion were independent risk factors for OS.

Conclusion

HCC with liver cirrhosis has specific characteristics. Compared with patients without cirrhosis, patients with cirrhosis have worse long-term survival after surgery. In addition, the independent risk factors for RFS and OS are different between patients with cirrhosis and without cirrhosis; liver cirrhosis is an independent risk factor for the long-term prognosis of HCC patients, especially patients with BCLC stage 0-B disease after hepatectomy.
Literature
1.
go back to reference Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021.
2.
go back to reference Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma[J]. J Hepatol. 2018;69(1):182–236.CrossRef Galle PR, Forner A, Llovet JM, et al. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma[J]. J Hepatol. 2018;69(1):182–236.CrossRef
3.
go back to reference Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers. 2021;7(1):6.CrossRef Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma[J]. Nat Rev Dis Primers. 2021;7(1):6.CrossRef
4.
go back to reference Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91.CrossRef Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J (Engl). 2021;134(7):783–91.CrossRef
5.
go back to reference Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–2015: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 2018;6(5):e555.CrossRef Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–2015: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 2018;6(5):e555.CrossRef
6.
go back to reference Zhang BH, Zhang BX, Zhang Z, et al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci. 2018;61(6):660–70.CrossRef Zhang BH, Zhang BX, Zhang Z, et al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci. 2018;61(6):660–70.CrossRef
7.
go back to reference Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective[J]. J Hepatol. 2019;71(1):212–21.CrossRef Xiao J, Wang F, Wong NK, et al. Global liver disease burdens and research trends: analysis from a Chinese perspective[J]. J Hepatol. 2019;71(1):212–21.CrossRef
8.
go back to reference Wang M, Wang Y, Feng X, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: experience of the Chinese National Cancer Center[J]. Int J Infect Dis. 2017;65:15–21.CrossRef Wang M, Wang Y, Feng X, et al. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: experience of the Chinese National Cancer Center[J]. Int J Infect Dis. 2017;65:15–21.CrossRef
10.
go back to reference Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–17.CrossRef Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–17.CrossRef
11.
go back to reference Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group[J]. Ann Surg. 2013;257(5):929–37.CrossRef Torzilli G, Belghiti J, Kokudo N, et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group[J]. Ann Surg. 2013;257(5):929–37.CrossRef
12.
go back to reference Xu W, Li R, Liu F. Novel prognostic nomograms for predicting early and late recurrence of hepatocellular carcinoma after curative hepatectomy cancer. Manag Res. 2020;9(12):1693–712. Xu W, Li R, Liu F. Novel prognostic nomograms for predicting early and late recurrence of hepatocellular carcinoma after curative hepatectomy cancer. Manag Res. 2020;9(12):1693–712.
13.
go back to reference Wang W, Li J, Pan R, et al. Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function[J]. Hep Intl. 2015;9(4):621–6.CrossRef Wang W, Li J, Pan R, et al. Association of the Laennec staging system with degree of cirrhosis, clinical stage and liver function[J]. Hep Intl. 2015;9(4):621–6.CrossRef
14.
go back to reference Kanazawa A, Tsukamoto T, Shimizu S, et al. Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis[J]. Surg Endosc. 2013;27(7):2592–7.CrossRef Kanazawa A, Tsukamoto T, Shimizu S, et al. Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis[J]. Surg Endosc. 2013;27(7):2592–7.CrossRef
Metadata
Title
Postoperative survival analysis of hepatocellular carcinoma patients with liver cirrhosis based on propensity score matching
Authors
Zhaoqin Wu
Haodong Tang
Lishan Wang
Xiaoling Jin
Zhengqing Lei
Pinghua Yang
Jiahua Zhou
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Surgery / Issue 1/2022
Electronic ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-022-01556-5

Other articles of this Issue 1/2022

BMC Surgery 1/2022 Go to the issue